Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level

Atallah, NM; Alsaleem, M; Toss, MS; Mongan, NP; Rakha, E

Rakha, E (通讯作者),Univ Nottingham, Sch Med, Div Canc & Stem Cells, Nottingham, England.;Rakha, E (通讯作者),Nottingham Univ Hosp NHS Trust, Nottingham, England.;Rakha, E (通讯作者),Menoufia Univ, Fac Med, Dept Pathol, Shibin Al Kawm, Egypt.

BRITISH JOURNAL OF CANCER, 2023; 129 (10): 1692

Abstract

Background: Increasing data indicate that HER2-positive (HER2 + ) breast cancer (BC) subtypes exhibit differential responses to targeted anti-HER2 the......

Full Text Link